elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35108695-B9E4E20C-9221-4429-BC83-AF2083AE6C33
Q35108695-B9E4E20C-9221-4429-BC83-AF2083AE6C33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35108695-B9E4E20C-9221-4429-BC83-AF2083AE6C33
Abrogation of TNFα production during cancer immunotherapy is crucial for suppressing side effects due to the systemic expression of IL-12.
P2860
Q35108695-B9E4E20C-9221-4429-BC83-AF2083AE6C33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35108695-B9E4E20C-9221-4429-BC83-AF2083AE6C33
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc6e2921e1474d948c2b2a07f4621f03cf51fc24
P2860
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.